BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Freitas AC, de Oliveira THA, Barros MR Jr, Venuti A. hrHPV E5 oncoprotein: immune evasion and related immunotherapies. J Exp Clin Cancer Res 2017;36:71. [PMID: 28545552 DOI: 10.1186/s13046-017-0541-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Balaji D, Kalarani IB, Mohammed V, Veerabathiran R. Potential role of human papillomavirus proteins associated with the development of cancer. VirusDis . [DOI: 10.1007/s13337-022-00786-8] [Reference Citation Analysis]
2 Ntuli L, Mtshali A, Mzobe G, Liebenberg LJ, Ngcapu S. Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection. Front Cell Infect Microbiol 2022;12:927131. [DOI: 10.3389/fcimb.2022.927131] [Reference Citation Analysis]
3 Barillari G, Bei R, Manzari V, Modesti A. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events? Int J Mol Sci 2021;22:13543. [PMID: 34948338 DOI: 10.3390/ijms222413543] [Reference Citation Analysis]
4 Blanco R, Carrillo-Beltrán D, Corvalán AH, Aguayo F. High-Risk Human Papillomavirus and Epstein-Barr Virus Coinfection: A Potential Role in Head and Neck Carcinogenesis. Biology (Basel) 2021;10:1232. [PMID: 34943147 DOI: 10.3390/biology10121232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pešut E, Đukić A, Lulić L, Skelin J, Šimić I, Milutin Gašperov N, Tomaić V, Sabol I, Grce M. Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge. Viruses 2021;13:2234. [PMID: 34835040 DOI: 10.3390/v13112234] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Ranieri D, French D, Raffa S, Guttieri L, Torrisi MR, Belleudi F. Expression of the E5 Oncoprotein of HPV16 Impacts on the Molecular Profiles of EMT-Related and Differentiation Genes in Ectocervical Low-Grade Lesions. Int J Mol Sci 2021;22:6534. [PMID: 34207106 DOI: 10.3390/ijms22126534] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Voutsadakis IA. PI3KCA Mutations in Uterine Cervix Carcinoma. J Clin Med 2021;10:E220. [PMID: 33435133 DOI: 10.3390/jcm10020220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Golrokh Mofrad M, Taghizadeh Maleki D, Faghihloo E. The roles of programmed death ligand 1 in virus-associated cancers. Infection, Genetics and Evolution 2020;84:104368. [DOI: 10.1016/j.meegid.2020.104368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Silva RCO, da Silva Júnior AHP, Gurgel APAD, Barros Junior MR, Santos DL, de Lima RCP, Batista MVA, Pena LJ, Chagas BS, Freitas AC. Structural and functional impacts of E5 genetic variants of human papillomavirus type 31. Virus Res 2020;290:198143. [PMID: 32871208 DOI: 10.1016/j.virusres.2020.198143] [Reference Citation Analysis]
10 Li N, Jiang D, He Q, He F, Li Y, Deng C, Li F. microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2. Cell Death Dis 2020;11:462. [PMID: 32541687 DOI: 10.1038/s41419-020-2668-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mestre VF, Medeiros-Fonseca B, Estêvão D, Casaca F, Silva S, Félix A, Silva F, Colaço B, Seixas F, Bastos MM, Lopes C, Medeiros R, Oliveira PA, Gil da Costa RM. HPV16 is sufficient to induce squamous cell carcinoma specifically in the tongue base in transgenic mice. J Pathol 2020;251:4-11. [PMID: 31994197 DOI: 10.1002/path.5387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
12 Vescovo T, Pagni B, Piacentini M, Fimia GM, Antonioli M. Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development. Front Cell Dev Biol 2020;8:47. [PMID: 32181249 DOI: 10.3389/fcell.2020.00047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
13 Vashisht S, Mishra H, Mishra PK, Ekielski A, Talegaonkar S. Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human Papillomavirus. Curr Pharm Biotechnol 2019;20:1260-80. [PMID: 31376818 DOI: 10.2174/1389201020666190802115722] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, Gao C, Ma D, Liao S. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Letters 2020;471:88-102. [DOI: 10.1016/j.canlet.2019.11.039] [Cited by in Crossref: 40] [Cited by in F6Publishing: 82] [Article Influence: 20.0] [Reference Citation Analysis]
15 Heft Neal ME, Haring CT, Mann JE, Brenner JC, Spector ME, Swiecicki PL. Novel Immunotherapeutic Approaches in Head and Neck Cancer. J Cancer Metastasis Treat 2019;5:76. [PMID: 32661502 DOI: 10.20517/2394-4722.2019.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis. Microorganisms 2019;7:E199. [PMID: 31337018 DOI: 10.3390/microorganisms7070199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
17 Syrjänen S. Oral manifestations of human papillomavirus infections. Eur J Oral Sci 2018;126 Suppl 1:49-66. [PMID: 30178562 DOI: 10.1111/eos.12538] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
18 Massa S, Paolini F, Marino C, Franconi R, Venuti A. Bioproduction of a Therapeutic Vaccine Against Human Papillomavirus in Tomato Hairy Root Cultures. Front Plant Sci 2019;10:452. [PMID: 31031788 DOI: 10.3389/fpls.2019.00452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Estêvão D, Costa NR, Gil da Costa RM, Medeiros R. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Biochim Biophys Acta Gene Regul Mech 2019;1862:153-62. [PMID: 30707946 DOI: 10.1016/j.bbagrm.2019.01.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
20 Wang X, Huang X, Zhang Y. Involvement of Human Papillomaviruses in Cervical Cancer. Front Microbiol 2018;9:2896. [PMID: 30546351 DOI: 10.3389/fmicb.2018.02896] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
21 Araldi RP, Sant’ana TA, Módolo DG, de Melo TC, Spadacci-morena DD, de Cassia Stocco R, Cerutti JM, de Souza EB. The human papillomavirus (HPV)-related cancer biology: An overview. Biomedicine & Pharmacotherapy 2018;106:1537-56. [DOI: 10.1016/j.biopha.2018.06.149] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
22 Barros MR Jr, de Melo CML, Barros MLCMGR, de Cássia Pereira de Lima R, de Freitas AC, Venuti A. Activities of stromal and immune cells in HPV-related cancers. J Exp Clin Cancer Res 2018;37:137. [PMID: 29976244 DOI: 10.1186/s13046-018-0802-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
23 Barillari G, Monini P, Sgadari C, Ensoli B. The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies. Int J Mol Sci 2018;19:E1418. [PMID: 29747434 DOI: 10.3390/ijms19051418] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Barros MR Jr, de Oliveira THA, de Melo CML, Venuti A, de Freitas AC. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers. J Immunol Res 2018;2018:2912671. [PMID: 29854832 DOI: 10.1155/2018/2912671] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
25 Schönrich G, Raftery MJ. CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil". Front Immunol 2018;9:545. [PMID: 29616036 DOI: 10.3389/fimmu.2018.00545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cordeiro MN, De Lima RDCP, Paolini F, Melo ARDS, Campos APF, Venuti A, De Freitas AC. Current research into novel therapeutic vaccines against cervical cancer. Expert Review of Anticancer Therapy 2018;18:365-76. [DOI: 10.1080/14737140.2018.1445527] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
27 Wu R, Paolini F, Frank D, Kamdar D, Curzio G, Pichi B, Pellini R, Spriano G, Bonagura VR, Venuti A, Steinberg BM. Latent human papillomavirus type 16 infection is widespread in patients with oropharyngeal cancers. Oral Oncol 2018;78:222-4. [PMID: 29433803 DOI: 10.1016/j.oraloncology.2018.01.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Yasunaga JI, Matsuoka M. Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development. Cancer Sci 2018;109:24-32. [PMID: 29143406 DOI: 10.1111/cas.13443] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
29 Araújo R, Santos JMO, Fernandes M, Dias F, Sousa H, Ribeiro J, Bastos MMSM, Oliveira PA, Carmo D, Casaca F, Silva S, Medeiros R, Gil da Costa RM. Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice. J Cancer Res Clin Oncol 2018;144:241-8. [DOI: 10.1007/s00432-017-2549-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]